

Res Judicata: Avoiding Preclusion Confusion in Derivative Litigation

Commercial Division Denies Pfizer’s Motion To Dismiss, Holds Allergan’s Claims for Defense Costs Are Ripe

Equitable Tolling: “Estopping” the Clock from Running on Your Claims

Commercial Division Judge Reaffirms “Most Critical” Element for Injunctive Relief: Irreparable Harm

Affirmatively Plead Your Defenses, or Risk “Waiving” Them Goodbye

Three New Rule Amendments Proposed by the Commercial Division Advisory Council

New York, Not Swiss Law Applies to Lawsuit Over “Stolen” $40M Princie Diamond

Summary Judgment 102: Make Sure Your “Money Instrument” Is In Tune With CPLR 3213
